Association of lipid profile with obesity among breast cancer survivors: a cross-sectional study

Okekunle, Akinkunmi Paul; Yie, Ga-Eun; Song, Sihan; Kim, Zisun; Youn, Hyun Jo; Cho, Jihyoung; Min, Jun Won; Kim, Yoo Seok; Lee, Jung Eun

doi:10.1186/s12944-022-01674-2

Lipids in Health and Disease

Table 2 Multivariable adjusted least square (LS) means and 95% confidence interval (CI)s of BMI (kg/m²) according to the distribution of lipid profiles among all breast cancer survivors

From: Association of lipid profile with obesity among breast cancer survivors: a cross-sectional study

	LS means^a and 95% CIs of BMI (kg/m²) by plasma lipid markers
Lipid Profile	Tertile 1	Tertile 2	Tertile 3	P-trend
Cholesterol (mmol/L)
Total-C	23.7 (23.1, 24.3)	23.2 (22.6, 23.8)	22.9 (22.4, 23.6)	0.05
non-HDL-C	23.4 (22.9, 24.0)	23.3 (22.8, 23.9)	23.1 (22.5, 23.8)	0.56
Remnant-C	23.3 (22.7, 23.9)	23.3 (22.7, 23.8)	23.4 (22.8, 23.9)	0.79
VLDL-C	22.8 (22.3, 23.4)	23.6 (22.9, 24.1)	23.5 (22.9, 24.1)	0.17
Clinical LDL-C	23.7 (23.1, 24.3)	23.3 (22.8, 23.9)	22.8 (22.3, 23.4)	0.05
LDL-C^b	23.7 (23.1, 24.2)	23.2 (22.6, 23.8)	23.0 (22.4, 23.6)	0.19
HDL-C	23.5 (22.9, 24.1)	23.7 (23.1, 24.2)	22.7 (22.1, 23.3)	0.03
Triglycerides (mmol/L)
Total-TG	22.8 (22.2, 23.3)	22.9 (22.4, 23.5)	24.2 (23.6, 24.8)	< 0.001^§
VLDL-TG	22.6 (22.1, 23.2)	23.1 (22.5, 23.7)	24.2 (23.6, 24.7)	< 0.001^§
LDL-TG	22.9 (22.3, 23.5)	23.1 (22.5, 23.7)	23.9 (23.3, 24.4)	0.009
HDL-TG	22.9 (22.4, 23.6)	23.2 (22.7, 23.8)	23.7 (23.1,24.3)	0.008
Phospholipids (mmol/L)
Total-PL	23.5 (22.9, 24.0)	23.2 (22.6, 23.7)	23.3 (22.7, 23.9)	0.45
VLDL-PL	22.8 (22.2, 23.3)	23.3 (22.7, 23.9)	23.8 (23.2, 24.4)	0.009
LDL-PL	23.7 (23.1, 24.2)	23.2 (22.6, 23.7)	23.1 (22.5, 23.6)	0.17
HDL-PL	23.4 (22.9, 24.0)	23.5 (22.9, 24.0)	22.9 (22.3, 23.5)	0.62
Cholesteryl esters (mmol/L)
Total-CE	23.7 (23.1, 24.2)	23.4 (22.8, 23.9)	22.9 (22.3, 23.5)	0.07
VLDL-CE	22.9 (22.4, 23.5)	23.5 (22.9, 24.1)	23.4 (22.8, 23.9)	0.34
LDL-CE	23.5 (22.9, 24.1)	23.5 (22.9, 24.1)	22.9 (22.3, 23.5)	0.35
HDL-CE	23.7 (23.1, 24.2)	23.6 (23.0, 24.2)	22.7 (22.1, 23.2)	0.01
Free Cholesterol (mmol/L)
Total-FC	23.2 (22.6, 23.8)	23.7 (23.1, 24.2)	22.9 (22.4, 23.6)	0.74
VLDL-FC	22.8 (22.3, 23.4)	23.3 (23.1, 24.3)	23.7 (23.1, 24.3)	0.04
LDL-FC	23.9 (23.3, 24.5)	23.2 (22.7, 23.8)	22.8 (22.2, 23.3)	0.005
HDL-FC	23.5 (22.9, 24.1)	23.3 (22.7, 23.9)	23.0 (22.5, 23.6)	0.13
Total Lipids (mmol/L)
Total-L	23.4 (22.9, 24.1)	22.9 (22.4, 23.5)	23.5 (22.9, 24.0)	0.83
VLDL-L	22.9 (22.3, 23.4)	23.0 (22.5, 23.6)	24.0 (23.4, 24.6)	0.002
LDL-L	23.5 (22.9, 24.1)	23.4 (22.8, 23.9)	23.0 (22.5, 23.6)	0.34
HDL-L	23.4 (22.8, 24.0)	23.6 (23.0, 24.2)	22.9 (22.4, 23.5)	0.19
Lipoprotein particle (mmol/L)
Total-LP	23.2 (22.7, 23.8)	23.7 (23.2, 24.3)	22.9 (22.3, 23.5)	0.39
VLDL-LP	22.9 (22.4, 23.6)	23.1 (22.5, 23.6)	23.9 (23.3, 24.4)	0.01
LDL-LP	23.3 (22.7, 23.9)	23.2 (22.7, 23.80	23.4 (22.8, 23.9)	0.89
HDL-LP	23.3 (22.7, 23.8)	23.6 (23.1, 24.2)	22.9 (22.4, 23.6)	0.27
Lipoprotein particle sizes (nm)
VLDL-p	22.7 (22.2, 23.3)	23.3 (22.7, 23.8)	23.9 (23.3, 24.4)	0.009
LDL-p	23.7 (23.2, 24.3)	23.3 (22.7, 23.8)	22.9 (22.3, 23.5)	0.09
HDL-p	23.9 (23.4, 24.5)	23.5 (22.9, 24.0)	22.5 (21.9, 23.1)	< 0.001^§

^aModels were adjusted for age (years, continuous), menopausal status at BC diagnosis (pre-menopause, post-menopause), highest education completed (middle school, high school, college education and above), ever smoked (no, yes), current alcohol use (no, yes), family history of breast cancer (no, yes), history of chronic disease (no, yes) and physical activity (MET-hours/week, continuous)
^bLDL-C was estimated from Friedewald’s equation. Clinical LDL-C and LDL-C are the same biomarker but refer to different definition methods [30]
^§P-trend was signifincant at Bonferroni corrected P-value = 0.00147

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com